news center.
2026-11-03
Meet Us at CPHI India 2026! | Booth No. 2A47
Beijing Lunarsun Pharmaceutical Co., Ltd. (Lunarsun) will participate in CPHI India 2026, taking pla...
2026-07-21
Great News | Imported API Furosemide Receives NMPA Marketing Approval
Our company's imported active pharmaceutical ingredient (API) Furosemide has officially received...
2026-07-10
NMPA-Approved Vonoprazan Fumarate Tablets – Seeking Global Partners
We are pleased to announce that Lunarsun Pharma's Vonoprazan Fumarate Tablets have obtained NMPA...